M2Gen Board of Directors

M2Gen® is a health informatics solutions company focused on accelerating the discovery and development of personalized medicines. M2Gen partners with the nation’s leading cancer centers through ORIEN to create a large, cancer-focused data warehouse linking clinical and molecular data. Using this information, M2Gen helps biopharmaceutical companies address the greatest challenges in oncology drug development.

Dr. William Dalton
William S. Dalton, Ph.D., M.D., Executive Chair
Past Director, Personalized Medicine Institute, Moffitt Cancer Center

Tim Adams
Mr. Timothy J. Adams
Retired/Past President, Time Customer Service, Inc.

James Asher
Mr. James M. Asher
Senior Vice President, Chief Legal &  Development Officer, Hearst Health

Greg Dorn
Gregory Dorn, M.D., MPH
President, Hearst Health

Alan List
Alan F. List, M.D.
President & CEO, Moffitt Cancer Center


Mr. Fred Lynch
President & CEO, Masonite Corporation

Richard Malloch
Mr. Richard P. Malloch
President, Hearst Business Media

Allan Martin
Mr. Allan S. Martin
Co-Founder & CEO, Lumina Analytics

Raphael Pollock
Raphael E. Pollock, MD, PhD, FACS (Non-voting, OSU Observer Designee)
Director, The Ohio State University Comprehensive Cancer Center


Mr. Robert Rothman
President & CEO, Black Diamond Group

Thomas Sellers
Thomas Sellers, Ph.D., MPH
Center Director, Moffitt Cancer Center

Steve Swartz
Mr. Steven R. Swartz (Non-voting, OSU Observer Designee)
President & CEO, Hearst Health